US 8323706
Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis
granted A61KA61K36/48A61P
Quick answer
US patent 8323706 (Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K36/48, A61P, A61P35/00